Prof. Caroline Gordon

February 27, 2018 7:23 pm Published by

Professor Caroline Gordon graduated from Cambridge University and trained in internal medicine, rheumatology and immunology in London and San Francisco. She joined the Faculty of the University of Birmingham in 1989 establishing clinical and research programs focus on lupus and pregnancy and the rheumatic diseases.

The Birmingham lupus clinics were the first to receive the title of LUPUS UK Centre of Excellence (2005). She is a member of the British Isles Lupus Assessment Group (BILAG), SLICC, and has been Co-Chair of the EULAR SLE Task Force. Her work has focused on disease assessment for clinical trials and outcome studies, particularly the development of the BILAG disease activity index and the epidemiology of lupus.

Caroline has led and participated in clinical trials, led the initiative producing EULAR points to consider for conducting SLE clinical trials, and advises the pharmaceutical industry on the design, implementation and analysis of trials. She is a consultant to the CDC on epidemiological studies of lupus in the USA. She has been closely involved in the development of the BSR guidelines for drugs in pregnancy in the rheumatic diseases and has been the lead for the BSR guidelines for the management of SLE.

Caroline has received numerous awards including the Edmund L. Dubois Memorial Award (American College of Rheumatology, 2002) and the Heberden Medal for Rheumatology ( BSR, 2013).

Categorised in:

This post was written by admin